Peptides DB
Research-centric peptide and protocol reference hub
Study 20 of 21Carbetocin literatureAnimal reproduction science · Observational2026

Administering carbetocin before electroejaculation in bulls improves semen quality and increases the number of insemination doses.

Carbetocin may slightly improve semen quality and yield in bulls, but the clinical significance of these findings remains uncertain.

Read at Animal reproduction scienceAdd to compare

Where it sits

this study against the rest of the carbetocin corpus
2
Preclinical
14
Observational · this one
0
Open-label
3
Randomised
2
Reviews

Summary and findings

The study measured the effects of carbetocin on semen yield and quality in 29 Braford bulls. Carbetocin was administered at a dose of 0.2 mg/100 kg body weight intravenously 15 minutes before electroejaculation. Results indicated slight enhancements in semen quality and quantity compared to control treatments.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Slightly enhanced semen mass motility (P = 0.05).n=292026

Abstract

The authors’ words, as Animal reproduction science supplied them

It was recently reported that administering carbetocin before electroejaculation in rams improves quantitative and qualitative characteristics of fresh semen; therefore, the hypothesis was that its use in bulls improves collection conditions in the field. The aim of the study was to determine whether administering carbetocin 15 min before electroejaculation improves semen yield in bulls, and whether these effects are associated with post-thaw sperm quality and sperm cryoresistance. Semen was collected from 29 Braford bulls in a two-period crossover study. Semen was collected from each bull after administering carbetocin (0.2 mg/100 kg body weight, IV) 15 min before electroejaculation, or without carbetocin (control treatment). The treatments were rotated so that all bulls received both. Carbetocin administered 15 min before electroejaculation slightly enhanced semen mass motility (P = 0.05) and moderately increased the number of calculated insemination doses (P = 0.05) compared to control bulls. In addition, it tended to increase the total number of sperm in the ejaculate, the total number of motile sperm, the number of sperm with functional membranes, and the number of sperm without bent tails in fresh semen, as well as the number of effective insemination doses in thawed semen (P = 0.09, P = 0.07, P = 0.06, P = 0.09, and P = 0.08, respectively). Carbetocin administration before electroejaculation in bulls marginally improved fresh semen quality and quantity, including motility and the number of fresh semen insemination doses. This may support routine use in artificial insemination programs by making the collection process more efficient.

Background

This paper investigates whether carbetocin can enhance semen quality and yield in bulls during electroejaculation, building on previous findings in rams. Prior studies indicated that carbetocin improved semen characteristics, but its effects in bulls had not been thoroughly examined. Understanding these effects could have implications for improving artificial insemination practices in cattle.

Methods

The study utilized a two-period crossover design with 29 Braford bulls. Each bull received either carbetocin (0.2 mg/100 kg body weight, IV) or a control treatment before electroejaculation, with treatments rotated. The primary outcome measures included semen yield and quality parameters assessed post-collection.

Results

Carbetocin administration resulted in a slight enhancement in semen mass motility (P = 0.05) and a moderate increase in the number of calculated insemination doses (P = 0.05). Additionally, there were trends towards increased total sperm count (P = 0.09), total motile sperm (P = 0.07), and other quality metrics, although these did not reach statistical significance.

Interpretation

While the findings suggest a potential benefit of carbetocin in improving semen quality and yield, the effect sizes are modest and may not be clinically meaningful. The results are consistent with previous research on rams but should be interpreted cautiously due to the small sample size and the presence of several outcomes that only approached significance. These limitations may affect the applicability of the findings in practical settings.

Key findings

  • Slightly enhanced semen mass motility (P = 0.05).
  • Moderately increased the number of calculated insemination doses (P = 0.05).
  • Tended to increase total number of sperm in the ejaculate (P = 0.09).
  • Tended to increase total number of motile sperm (P = 0.07).
  • Tended to increase number of sperm with functional membranes (P = 0.06).
  • Tended to increase number of sperm without bent tails (P = 0.09).

Limitations

  • Small sample size of 29 bulls.
  • Several outcomes only trending towards significance.
  • Crossover design may introduce carryover effects.
  • Single-site study limits generalizability.
  • No long-term follow-up on semen quality.

Elsewhere in the Carbetocin corpus

ATiming of carbetocin administration in vaginal deliveries: a double-blind, randomized controlled trial.Journal of perinatal medicine · 2025 · n=160 · Incidence of PPH was significantly lower in the carbetocin-before group than in the carbetocin-after group (p=0.015).HumanBReplacing Routine Oxytocin Infusion With Single-Dose Carbetocin at Elective Caesarean Section: A Service Improvement Evaluation of Postpartum Haemorrhage Outcomes.Cureus · 2024 · n=838 · Significant postpartum haemorrhage rates of 2.55% for oxytocin and 2.69% for carbetocin.HumanBInduction of labor versus cesarean section after 36 + 0 weeks in twin pregnancy: A review of maternal and neonatal outcomes.Acta obstetricia et gynecologica Scandinavica · 2023 · n=708 · 71.2% (n=272) achieved vaginal delivery of both babies in the IOL group.reviewBMagnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) therapy of uterine fibroids effectively reduces both bleeding and bulk symptoms-A prospective single-center 12-month follow-up study.Acta obstetricia et gynecologica Scandinavica · 2023 · n=163 · Overall mean NPV% for all patients was 62%.HumanBFive-Year Trends in Obstetric Hemorrhage, Hemostatic Management, and Blood Product Utilization at a Tertiary Maternity Center in Kazakhstan: A Retrospective Time-Series Study.Healthcare (Basel, Switzerland) · 2023 · n=46554 · Recorded hemorrhage rate fell from 11.39 to 3.62 per 1000 deliveries, rate ratio 0.318, 95% CI 0.217-0.466.reviewACarbetocin vs oxytocin for prevention of postpartum hemorrhage in women with obesity undergoing cesarean delivery: A systematic review and meta-analysis.Journal of gynecology obstetrics and human reproduction · 2026 · n=269 · MD -230.11 ml blood loss with carbetocin vs oxytocin; 95% CI -370.90 to -89.33; p = 0.0014review